Treating Pediatric Cancers

Here is a link to an article about the surprising success of using Crizotinib to treat three pediatric cancers (anaplastic large cell lymphoma(ALCL), inflammatory myofibroblastic tumors, and neuroblastomas).

For example, 88% of the treated ALCL Patients experienced a complete response with no detectable disease.

This entry was posted in Anaplastic Large-Cell Lymphomas, Neuroblastomas, Potential Treatments. Bookmark the permalink.

Leave a Reply